Capital Analysts LLC’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17K Sell
256
-148
-37% -$9.83K ﹤0.01% 1055
2025
Q1
$28K Sell
404
-100
-20% -$6.93K ﹤0.01% 917
2024
Q4
$43K Buy
504
+53
+12% +$4.52K ﹤0.01% 782
2024
Q3
$54K Buy
451
+332
+279% +$39.8K ﹤0.01% 709
2024
Q2
$17K Sell
119
-60
-34% -$8.57K ﹤0.01% 883
2024
Q1
$23K Buy
179
+140
+359% +$18K ﹤0.01% 797
2023
Q4
$4K Sell
39
-29
-43% -$2.97K ﹤0.01% 979
2023
Q3
$6K Buy
+68
New +$6K ﹤0.01% 960
2023
Q2
Sell
-50
Closed -$4K 1023
2023
Q1
$4K Buy
+50
New +$4K ﹤0.01% 886
2021
Q3
Sell
-70
Closed -$3K 1016
2021
Q2
$3K Sell
70
-1,750
-96% -$75K ﹤0.01% 854
2021
Q1
$61K Buy
1,820
+1,750
+2,500% +$58.7K ﹤0.01% 555
2020
Q4
$2K Buy
+70
New +$2K ﹤0.01% 697
2016
Q4
Sell
-7,240
Closed -$151K 379
2016
Q3
$151K Buy
+7,240
New +$151K 0.03% 185